US Stocks Watchlist – 30 January 2023
The full post is available to view by members only. For immediate access:
The market pulled back today at key resistance, with multiple market indexes testing their Stage 2 levels at the end of last week. The Fed meeting looms over the market this week, which will be a key driver as to whether the market breaks out into a potential early Stage 2 environment or fails once more and reverses lower – which was the pattern through 2022. So it could be a pivotal week.
Earnings season also picks up more speed this week, with hundreds of stocks reporting, but then gets going in full from next Monday 6th February.
There were 23 stocks highlighted from the US stocks watchlist scans today
ARHS, EXPE, FCX, IOT + 19 more...
*Breadth data and charts were posted earlier in the day before the market open on the Private Twitter Feed, as I was away over the weekend. But I thought it would be useful to post a couple of the key charts here too as not all members access the Private Twitter Feed.
Cumulative Point and Figure Breakouts - Breakdowns
Note: The cumulative line moved above the 200 day MA for the first time since December 2021 last week.
IBD Industry Groups Bell Curve – Bullish %
Average Distribution: 54.82% (+4.09% 1wk)
- 38 Groups (19%) in Stage 4 zone
- 81 Groups (40.5%) in Stage 1 or Stage 3 zone
- 81 Groups (40.5%) in Stage 2 zone
Become a Stage Analysis Member:
To see more like this and other premium content, such as the regular US Stocks watchlist, detailed videos and intraday posts, become a Stage Analysis member.
Disclaimer: For educational purpose only. Not investment advice. Seek professional advice from a financial advisor before making any investing decisions.